Literature DB >> 8421085

Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance.

M J McPhaul1, M Marcelli, S Zoppi, J E Griffin, J D Wilson.   

Abstract

Mutations in the androgen receptor gene cause phenotypic abnormalities of male sexual development that range from a female phenotype (complete testicular feminization) to that of undervirilized or infertile men. Using the tools of molecular biology, we have analyzed androgen receptor gene mutations in 31 unrelated subjects with androgen resistance syndromes. Most of the defects are due to nucleotide changes that cause premature termination codons or single amino acid substitutions within the open reading frame encoding the androgen receptor, and the majority of these substitutions are localized in three regions of the androgen receptor: the DNA-binding domain and two segments of the androgen-binding domain. Less frequently, partial or complete gene deletions have been identified. Functional studies and immunoblot assays of the androgen receptors in patients with androgen resistance indicate that in most cases the phenotypic abnormalities are the result of impairment of receptor function or decreases in receptor abundance or both.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421085     DOI: 10.1210/jcem.76.1.8421085

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

1.  Extreme androgen resistance in a kindred with a novel insertion/deletion mutation in exon 5 of the androgen receptor gene.

Authors:  Felipe Vilchis; Luis Ramos; Susana Kofman-Alfaro; Juan Carlos Zenteno; Juan Pablo Méndez; Bertha Chávez
Journal:  J Hum Genet       Date:  2003-06-07       Impact factor: 3.172

2.  An uncommon large deletion in the androgen-receptor gene in a XY female with complete androgen insensitivity syndrome.

Authors:  C Moretti; T Odorisio; R Geremia; P Grimaldi
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

Review 3.  Molecular determinants of sexual differentiation.

Authors:  J S Wiener; M Marcelli; D J Lamb
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

4.  A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release.

Authors:  B C Lin; S H Hong; S Krig; S M Yoh; M L Privalsky
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

5.  Presence of the Apert canonical S252W FGFR2 mutation in a patient without severe syndactyly.

Authors:  M R Passos-Bueno; A Richieri-Costa; A L Sertié; A Kneppers
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

6.  Implication of androgen receptor in urinary bladder cancer: a critical mini review.

Authors:  Arshad H Rahmani; Mohammad Alzohairy; Ali Yousif Y Babiker; Amjad A Khan; Salah M Aly; Moshahid A Rizvi
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

7.  Molecular characterization of the androgen receptor gene in boys with hypospadias.

Authors:  O Hiort; G Klauber; M Cendron; G H Sinnecker; L Keim; E Schwinger; H J Wolfe; D W Yandell
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

8.  Down syndrome in association with features of the androgen insensitivity syndrome.

Authors:  R M Viner; N Shimura; B D Brown; A J Green; I A Hughes
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

9.  A novel missense mutation in the amino-terminal domain of the human androgen receptor gene in a family with partial androgen insensitivity syndrome causes reduced efficiency of protein translation.

Authors:  C S Choong; C A Quigley; F S French; E M Wilson
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

10.  Sequence variation in the androgen receptor gene is not a common determinant of male sexual orientation.

Authors:  J P Macke; N Hu; S Hu; M Bailey; V L King; T Brown; D Hamer; J Nathans
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.